In another study, IDO was positively associated with chemoresistance in a gene expression profiling study aimed at identifying molecules associated with resistance to paclitaxel-based chemotherapy in ovarian cancer cell lines and refractory surgical ovarian cancer specimens [17]. This evidence concerns the gene IDO1 and ovarian cancer.